NSESpurt in Volume7 Sept 2026 · 7 Sept 2026, 08:31 pm

Spurt in Volume

Themis Medicare Limited · THEMISMED

✦ AI SummaryRegulatory

Themis Medicare Limited has responded to the exchange's query regarding the significant increase in volume of its securities, stating that there is no pending or delayed disclosure of material information. The company has been regularly disseminating relevant information and details in compliance with SEBI regulations.

Analysis Scores

Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk8/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Significant increase in volume has been observed in Themis Medicare Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Themis Medicare Limited has submitted their response.

Attachments (1)

📄

THEMISMED_07092026203123_ClarificationincinvolumeTML07092026NSE.pdf

pdf

Download →
View document text
TML/BSE/NSE/2026-27/22 07th September, 2026 Corporate Relationship Department Listing Department BSE Limited National Stock Exchange of India Limited Floor 25, Phiroze Jeejeebhoy Towers Exchange Plaza, Dalal Street, Mumbai- 400001 Bandra Kurla Complex, Scrip Code – 530199 Bandra (East), Mumbai- 400051 Symbol: THEMISMED Dear Sir / Madam, Sub: Clarification on Increase in Volume Movement of Themis Medicare Limited. Ref: Your email dated 07th September, 2026 for Clarification on Increase in Volume Movement. Dear Sir / Madam, This has reference to your email dated 07th September, 2026, seeking clarification on increase in volume of Company's securities. We would like to state that there is no pending or delay in disclosure or announcement relating to any material information in terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, in relation to the recent past. Kindly note that the Company has been regularly disseminating relevant information and details time to time whenever required to disclose in compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. We hope to have been clarified with your query. For Themis Medicare Limited, Sachin D. Patel Managing Director & CEO DIN: 00033353 Themis Medicare Limited Corporate Office: 11/12 Udyog Nagar, S V Road, Goregaon (W), Mumbai – 400 104, India *Tel.: 91-22-67607080*Fax: 91-22-67607070/ 28746621 Regd. Office: Plot No. 69-A, G.I.D.C., Industrial Estate, Vapi-Gujarat CIN No.: L24110GJ1969PLC001590 *Tel/ Fax No.: Regd. Off.: 0260-2431447/ 2430219 *E-mail: themis@themismedicare.com*Website: www.themismedicare.com